| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| FUNGISIL MK 10 mg/g | TERBINAFINUM | CREMA | D01AE15 | W52930001 | FITERMAN PHARMA S.R.L. - ROMANIA | ||||||
| FUNGISIL MK 10 mg/g | TERBINAFINUM | CREMA | D01AE15 | W52930002 | FITERMAN PHARMA S.R.L. - ROMANIA | ||||||
| FUNGISIL MK 10 mg/g | TERBINAFINUM | CREMA | D01AE15 | W52930003 | FITERMAN PHARMA S.R.L. - ROMANIA | ||||||
| FURAZOLIDON TERAPIA 100 mg | FURAZOLIDONUM | COMPR. | A07AXN1 | W03253001 | TERAPIA SA - ROMANIA | ||||||
| FURAZOLIDON TERAPIA 100 mg | FURAZOLIDONUM | COMPR. | A07AXN1 | W03253002 | TERAPIA SA - ROMANIA | ||||||
| FURAZOLIDONA ARENA 25 mg | FURAZOLIDONUM | COMPR. | A07AXN1 | W03255003 | ARENA GROUP S.A. - ROMANIA | ||||||
| FURAZOLIDONA FORTE ARENA 100 mg | FURAZOLIDONUM | COMPR. | A07AXN1 | W03256003 | ARENA GROUP S.A. - ROMANIA | ||||||
| FUROAT DE MOMETAZONA CIPLA 50 micrograme/doza | MOMETASONUM | SPRAY NAZ.,SUSP. | R01AD09 | W71062001 | CIPLA EUROPE NV - BELGIA | ||||||
| FUROAT DE MOMETAZONA SANDOZ 50 micrograme/doza | MOMETASONUM | SPRAY NAZ.,SUSP. | R01AD09 | W69617001 | SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA | ||||||
| FUROAT DE MOMETAZONA SANDOZ 50 micrograme/doza | MOMETASONUM | SPRAY NAZ.,SUSP. | R01AD09 | W69617002 | SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA | ||||||
| FUROAT DE MOMETAZONA SANDOZ 50 micrograme/doza | MOMETASONUM | SPRAY NAZ.,SUSP. | R01AD09 | W69617003 | SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA | ||||||
| FUROAT DE MOMETAZONA SANDOZ 50 micrograme/doza | MOMETASONUM | SPRAY NAZ.,SUSP. | R01AD09 | W69617004 | SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA | ||||||
| FUROAT DE MOMETAZONA SANDOZ 50 micrograme/doza | MOMETASONUM | SPRAY NAZ.,SUSP. | R01AD09 | W69617005 | SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA | ||||||
| FUROLIN 100 mg | NITROFURANTOINUM | CAPS. | J01XE01 | W70647001 | IASIS PHARMACEUTICALS HELLAS S.A. - GRECIA | ||||||
| FUROLIN 100 mg | NITROFURANTOINUM | CAPS. | J01XE01 | W70647002 | IASIS PHARMACEUTICALS HELLAS S.A. - GRECIA | ||||||
| FUROLIN 50 mg | NITROFURANTOINUM | CAPS. | J01XE01 | W70646001 | IASIS PHARMACEUTICALS HELLAS S.A. - GRECIA | ||||||
| FUROLIN 50 mg | NITROFURANTOINUM | CAPS. | J01XE01 | W70646002 | IASIS PHARMACEUTICALS HELLAS S.A. - GRECIA | ||||||
| FUROSEMID ARENA 40 mg | FUROSEMIDUM | COMPR. | C03CA01 | W52043001 | ARENA GROUP S.A. - ROMANIA | ||||||
| FUROSEMID ARENA 40 mg | FUROSEMIDUM | COMPR. | C03CA01 | W52043002 | ARENA GROUP S.A. - ROMANIA | ||||||
| FUROSEMID BASI 10 mg/ml | FUROSEMIDUM | SOL INJ./PERF. | C03CA01 | W69831001 | LABORATORIOS BASI-INDUSTRIA FARMACEUTICA S.A. - PORTUGALIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman